Overview

Detailed Summary

Checkpoint Trends Limited, previously known as Rubra Medicaments Ltd, was established in 1991 and is now involved in trading and consultancy services.
The company has transitioned from manufacturing pharmaceutical formulations to offering a broad array of consulting services across various sectors.
Checkpoint Trends Limited is actively exploring alternative business opportunities, indicating a shift in its strategic direction to diversify its offerings.
The company's operations now emphasize providing high-quality consulting services at competitive prices, showcasing its flexibility in adapting to market demands.

Sector: Pharmaceuticals & Biotechnology
Industry: Pharmaceuticals
Market Cap: 19 Cr
Volatility: Low Risk
P/E Ratio: 12.6
Industry P/E: 37.5
PEG Ratio: 0.0
P/B Ratio: 0.8
52W High: 144.40
52W Low: 28.22

Sales CAGR

1Y: -55.75%
3Y: -37.12%
5Y: -12.73%
10Y: 11.01%

Profit CAGR

1Y: —
3Y: —
5Y: -4.25%
10Y: —

ROE

TTM: 6.49%
3Y: -1.44%
5Y: -1.93%
10Y: -3.16%

ROCE

TTM: 7.62%
3Y: -0.63%
5Y: -0.85%
10Y: -2.23%

Technicals

‌

Forecasts

Peers

Healthcare Healthcare Pharmaceuticals

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
ISHITADR		75.27	23 Cr	28.86	1.95	0.00	6.73	9.78	6.19
VENMAX		16.68	19 Cr	96.60	1.37	0.00	1.76	1.92	1.23
CHECKPOINT		34.55	19 Cr	12.60	0.81	0.00	6.49	7.62	0.44
DESHRAK		31.00	18 Cr	30.98	1.36	0.00	4.23	5.80	2.73
MONOPHARMA		9.95	18 Cr	50.23	0.56	0.00	1.12	4.42	0.29
ZENITHHE		3.20	17 Cr	-155.36	2.30	0.00	0.07	0.33	0.00
VINRKLB		25.00	15 Cr	-60.28	0.00	0.00	20.74	-104.17	-21.01
Median: 7 Co.	—	25.00	18 Cr	28.86	1.36	0.00	4.23	4.42	0.44

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	0.17	0.47	0.10	0.05	0.10	0.25	12	109	174	279
Expenses	0.11	0.71	0.08	0.08	0.14	0.16	12	107	173	280
Operating Profit	0.06	-0.24	0.02	-0.03	-0.04	0.09	0.09	1.79	0.77	-0.38
OPM %	35.29	-51.06	20.00	-60.00	-40.00	36.00	0.77	1.65	0.44	-0.14
Other Income	0.00	0.00	0.00	0.00	0.02	-0.02	0.00	0.00	0.00	0.00
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	0.06	-0.24	0.02	-0.03	-0.02	0.07	0.09	1.80	0.77	-0.37
Tax %	0.00	4.17	0.00	-33.33	0.00	14.29	0.00	26.11	24.68	-29.73
Net Profit	0.06	-0.23	0.02	-0.04	-0.02	0.06	0.09	1.32	0.57	-0.48
EPS in Rs	0.10	-0.42	0.05	-0.08	-0.01	0.12	0.16	2.42	1.05	-0.09

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales	0.31	2.30	0.59	0.99	0.49	2.01	1.16	1.13	0.50	12
Expenses	0.27	2.33	0.77	0.97	0.48	2.03	1.24	1.10	0.45	12
Operating Profit	0.03	-0.03	-0.18	0.02	0.01	-0.02	-0.08	0.03	0.05	0.11
OPM %	10.42	-1.52	-30.73	1.81	2.06	-1.06	-6.84	2.55	10.90	0.91
Other Income	0.00	-0.13	0.17	0.00	0.00	0.00	0.00	0.00	0.00	NaN
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.01	0.00
Profit Before Tax	0.03	-0.16	-0.01	0.05	0.01	-0.02	-0.08	0.02	0.05	0.11
Tax %	0.00	0.00	0.00	31.93	30.96	-63.92	2.63	-34.57	46.41	18.18
Net Profit	0.03	-0.16	-0.01	0.03	0.01	-0.04	-0.08	0.03	0.03	0.09
EPS in Rs	0.07	-0.30	-0.02	0.05	0.01	-0.06	-0.13	0.05	0.08	3.54
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	5.47	5.47	5.47	5.47	5.47	5.47	5.47	5.47	5.47	5.47
Reserves	-5.08	-5.05	-4.88	-4.89	-4.86	-4.85	-4.89	-4.97	-4.94	-4.91
Borrowings	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.15	0.00	0.00
Other Liabilities	0.07	0.11	0.22	0.12	0.14	0.29	0.27	0.01	0.40	0.09
Total Liabilities	0.46	0.53	0.81	0.70	0.75	0.90	0.85	0.66	0.93	0.65
Fixed Assets	0.00	0.00	0.00	0.02	0.02	0.01	0.01	0.06	0.07	0.00
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	0.46	0.53	0.81	0.68	0.74	0.89	0.83	0.60	0.87	0.65
Total Assets	0.46	0.53	0.81	0.70	0.75	0.90	0.85	0.66	0.93	0.65

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	-0.01	0.04	0.18	-0.03	0.12	0.52	-0.50	0.01	-0.02	0.19
Cash from Investing Activity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.18
Cash from Financing Activity	-0.02	0.02	0.00	-0.17	-0.26	0.00	0.00	0.00	0.00	0.00
Net Cash Flow	-0.03	0.06	0.18	-0.20	-0.14	0.52	-0.50	0.01	-0.02	0.01

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoters	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	10.85%	10.86%	10.86%	10.71%	8.59%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	89.15%	89.14%	89.14%	89.29%	91.41%
Total Shareholders	1,700	1,712	1,722	1,981	2,039	2,073	2,123	2,204	2,277	2,416	2,396	2,457

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

Actions

Action Type

‌
‌

Announcements

Last 7 days

Sentiment

Sorry, no results found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.